Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal cancer: new models and approach for personalizing therapy.
di Martino S, De Luca G, Grassi L, Federici G, Alfonsi R, Signore M, Addario A, De Salvo L, Francescangeli F, Sanchez M, Tirelli V, Muto G, Sperduti I, Sentinelli S, Costantini M, Pasquini L, Milella M, Haoui M, Simone G, Gallucci M, De Maria R, Bonci D. di Martino S, et al. Among authors: de salvo l. J Exp Clin Cancer Res. 2018 Sep 5;37(1):217. doi: 10.1186/s13046-018-0874-4. J Exp Clin Cancer Res. 2018. PMID: 30185225 Free PMC article.
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition.
Cannistraci A, Federici G, Addario A, Di Pace AL, Grassi L, Muto G, Collura D, Signore M, De Salvo L, Sentinelli S, Simone G, Costantini M, Nanni S, Farsetti A, Coppola V, De Maria R, Bonci D. Cannistraci A, et al. Among authors: de salvo l. Oncogene. 2017 Jun 29;36(26):3718-3728. doi: 10.1038/onc.2016.505. Epub 2017 Feb 13. Oncogene. 2017. PMID: 28192399
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP, Costantini M, Copetti M, la Torre A, Sparaneo A, Fontana A, Poeta L, Gallucci M, Sentinelli S, Graziano P, Parente P, Pompeo V, De Salvo L, Simone G, Papalia R, Picardo F, Balsamo T, Flammia GP, Trombetta D, Pantalone A, Kok K, Paranita F, Muscarella LA, Fazio VM. Fabrizio FP, et al. Among authors: de salvo l. Oncotarget. 2017 Feb 14;8(7):11187-11198. doi: 10.18632/oncotarget.14492. Oncotarget. 2017. PMID: 28061437 Free PMC article.
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
Terrenato I, D'Alicandro V, Casini B, Perracchio L, Rollo F, De Salvo L, Di Filippo S, Di Filippo F, Pescarmona E, Maugeri-Saccà M, Mottolese M, Buglioni S. Terrenato I, et al. Among authors: de salvo l. PLoS One. 2017 Feb 10;12(2):e0171517. doi: 10.1371/journal.pone.0171517. eCollection 2017. PLoS One. 2017. PMID: 28187209 Free PMC article.
AMBRA1 and SQSTM1 expression pattern in prostate cancer.
Falasca L, Torino F, Marconi M, Costantini M, Pompeo V, Sentinelli S, De Salvo L, Patrizio M, Padula C, Gallucci M, Piacentini M, Malorni W. Falasca L, et al. Among authors: de salvo l. Apoptosis. 2015 Dec;20(12):1577-86. doi: 10.1007/s10495-015-1176-3. Apoptosis. 2015. PMID: 26423274 Free PMC article.
CD123 monoclonal antibody in myelodysplastic syndrome.
De Salvo L, Salas R, De Salvo D, Medina WJ, Nunez A, Plumacher Z, Fernandez O, Acosta M, Duerto M, Paz L, Salas D, Fuenmayor A. De Salvo L, et al. Hematol Oncol Stem Cell Ther. 2011;4(2):107. doi: 10.5144/1658-3876.2011.106. Hematol Oncol Stem Cell Ther. 2011. PMID: 21727775 Free article. No abstract available.
53 results